Upregulation of PIM 1 expression has been shown in prostate cancer following inhibition of AKT [20], providing further evidence for the idea of crosstalk between both PIM kinase and PI3K/AKT/mTOR pathways [21]. Here, AKT1 is linked to prostate carcinoma.